Eric J. Lehr

Eric J. Lehr

Auto-generated profile, based on publicly available information

Eric J. Lehr

Swedish Heart & Vasc Inst, Div Cardiac Surg, 1600 E Jefferson St,Ste 110, Seattle, WA 98122 USA

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2013 in Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery
Verified
Journal Article
Closed access
MSMukta C. Srivastava
Mukta C. Srivastava
MVMark R. Vesely
Mark R. Vesely
JLJeffrey D. Lee
Jeffrey D. Lee
ELEric J. Lehr
Eric J. Lehr
BWBrody Wehman
Brody Wehman
JBJohannes Bonatti
Johannes Bonatti
Objective: Hybrid coronary revascularization (HCR) is a treatment strategy for the revascularization of multivessel coronary disease that combines the advantages of both minimally invasive surgical techniques and percutaneous coronary intervention (PCI). The optimal sequence by which revascularization should be accomplished has not been determined. We investigated clinical outcomes in a series of patients planned for HCR via robotically assisted totally endoscopic coronary artery bypass (TECAB) and standard PCI based on revascularization sequence. Methods: A total of 238 patients planned for HCR between 2001 and 2011 were divided into three groups based on treatment sequence: (a) TECAB before PCI, (b) PCI before TECAB, and (c) same-session procedure. Multiple procedural and clinical end points before discharge and up to 2 years after the procedure were compared between the three groups in an intention-to-treat analysis. Demographic features were reviewed to determine baseline differences between each group. Results: Of the 238 patients, 175 (73.5%) underwent TECAB before PCI, 38 patients (16.0%) underwent PCI before TECAB, and 25 (10.5%) underwent a simultaneous revascularization procedure. At baseline, the patients undergoing TECAB before PCI were significantly older. There was a significantly higher incidence of previous myocardial infarction in the PCI-first group (P < 0.001). There was a significant difference in intensive care unit (ICU) length of stay (LOS), with shorter ICU stays in the simultaneous revascularization group (P = 0.031) and shorter hospital LOS in the PCI before TECAB group (P = 0.021). Conclusions: In conclusion, revascularization sequence did not dramatically impact clinical outcomes in our observational study. The patients undergoing PCI-first and same-session interventions had shorter hospital and ICU LOS compared with the patients undergoing surgery first. Our findings suggest that no revascularization approach is arbitrarily superior and that revascularization sequence should be individualized on the basis of patient presentation and anatomical considerations.

1 November 2010 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
ELEric J. Lehr
Eric J. Lehr
DZDavid Zimrin
David Zimrin
MVMark Vesely
Mark Vesely
POPatrick Odonkor
Patrick Odonkor
BGBartley Griffith
Bartley Griffith
JBJohannes Bonatti
Johannes Bonatti

1 July 2016 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Open access
PDF file
ELEric J. Lehr
Eric J. Lehr
Surgery of the heart has probably reached the limit set by nature to all surgery: no new method and no new discovery can overcome the natural difficulties that attend a wound of the heart.

23 December 2025 in European Heart Journal: Acute Cardiovascular Care
Verified
Journal Article
Closed access
IFIoannis Farmakis
Ioannis Farmakis
SHSteven Horbal
Steven Horbal
JMJohn M Moriarty
John M Moriarty
MEMahir Elder
Mahir Elder
TTThomas Todoran
Thomas Todoran
SKStavros Konstantinides
Stavros Konstantinides
Aims: Multidisciplinary pulmonary embolism response teams (PERTs) are being established in hospitals worldwide to address the increasing complexity in acute PE management. To identify recent trends in PERT decisions regarding advanced treatment of acute severe PE. Methods and results: We analysed data from the prospective multicentre PERT™ Consortium registry (years 2018–2024), focusing on catheter-directed treatment (CDT) and including systemic thrombolysis, surgical embolectomy, and extracorporeal membrane oxygenation (ECMO). An age-, sex-, and PE risk-matched population from the US Nationwide Inpatient Sample (NIS) was used for comparison. Among 11 436 patients enrolled at 51 sites (median age, 65 years; 13.7% high-risk and 62.5% intermediate-risk PE), 2639 (23.1%) underwent CDT. Of those, 140 (5.3%) underwent catheter-directed thrombolysis without ultrasound, 851 (32.2%) ultrasound-assisted catheter thrombolysis, and 1534 (58.1%) mechanical thrombectomy/aspiration. Systemic thrombolysis was used in 5.6%, surgical embolectomy in 1.1%, and ECMO in 1.6% of all patients. Trends of CDT increased over time (+0.36% quarterly by linear regression; P = 0.002), with increase in mechanical thrombectomy (+0.83%; P < 0.001) and decrease in catheter-directed thrombolysis (−0.4%; P = 0.001). Matching 10 883 patients from the PERT™ Consortium registry to the NIS population, we found a 22% (95% CI, 21–23%) standardized mean difference in CDT use, 1.3% (0.6–2.0%) lower in-hospital mortality, and 0.75 (0.2–1.3) fewer days of hospital stay among PERT™ Consortium registry patients. Conclusion: In a national quality assurance database of patients with PE included in the PERT registry, the use of catheter-directed treatment increased over time. Compared with a nationwide NIS sample, these patients had lower in-hospital mortality and shorter hospital length of stay.

24 September 2020 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
PDF file
ELEric J. Lehr
Eric J. Lehr
MZMing Zhang
Ming Zhang

21 February 2014
Verified
Book Chapter
Closed access
PDF file
ELEric J. Lehr
Eric J. Lehr
JBJohannes Bonatti
Johannes Bonatti